← Eichor
Condition: Resolution Of Inflammation Synced from ClinicalTrials.gov · July 28, 2026

Recruiting studies: Resolution Of Inflammation

Studies currently listed as recruiting on the public registry for this search term. Each page explains the study in plain language, with locations and the study team's contact details. Clinicians: generate a printable list for your patient →

Increased Inflammation-resolving Activity by Omega-3 Monoglycerides in Peripheral Blood Mononuclear Cells (PBMC).
Phase N/A · 1 location(s) · SCF Pharma · NCT05161702
Depemokimab Asthma Imaging and Bronchoscopy Sub-Study
Phase 3 · 50 location(s) · GlaxoSmithKline · NCT06979323
Gelaspan vs Crystalloid Therapy in Sepsis
Phase 4 · 9 location(s) · Shanghai Zhongshan Hospital · NCT07172451
An Efficacy and Safety Study of DFL24498 in the Treatment of AKC
Phase 3 · 19 location(s) · Dompé Farmaceutici S.p.A · NCT07395232
Local Antibiotics for Breast Implants
Phase 3 · 8 location(s) · Mikkel Herly · NCT04731025
Metformin in Patients With Unruptured Vertebrobasilar Dissecting Aneurysms (METTLE)
NA · 1 location(s) · Ming Lv · NCT06405971
Clinical Effects of Ringers Lactate Versus Sterofundin/ Plasmalyte Solution in Patients With Sepsis
NA · 1 location(s) · CMH Lahore Medical College and Institute of Dentistry · NCT07239713
Efficacy of Vevye Ophthalmic Solution for the Treatment of Meibomian Gland Dysfunction
Phase 4 · 1 location(s) · University of Alabama at Birmingham · NCT07224529
Outcomes of High-volume Saline Irrigation VS Povidone-Iodine Solution Cleaning of IOWI in Preventing SSIs in Emergency L
Phase 2/Phase 3 · 1 location(s) · Dow University of Health Sciences · NCT05989386
Look up another condition
Patient organization or foundation? You can brand this page for your community — your logo, your resources, same honest registry data, kept current daily. Ask about branding →

This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.